NEW YORK – NantHealth said Thursday after the close of the market that its first quarter revenues fell 10 percent year over year to $18.2 million from $20.2 million.
For the quarter ended March 31, NantHealth had total software-related revenues of $18.1 million, up 2 percent from $17.8 million in Q1 2019. All software-related revenues now come from software-as-a-service (SaaS) offerings.
Revenue from sequencing and molecular analysis slipped 93 percent to $59,000 from $814,000 a year earlier.